Clinical and Prognostic Correlates of the Reticulin-Collagen-Osteosclerosis Score in Primary Myelofibrosis
Modern Pathology · 2025
DOI: 10.1016/j.modpat.2025.100854 ↗Kurz gefasst
Fachartikel in der Zeitschrift Modern Pathology, 2025. Verfasst von Raffaella Santi und 11 weiteren Autor:innen. Beteiligte Einrichtung: Hematopathology Unit, Department of Diagnostic Services, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy; Department of Health Sciences, U…. Hauptthemen laut MEDLINE: Primary Myelofibrosis, Reticulin, Collagen, Osteosclerosis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Association for Cancer Research, Ministero dell’Istruzione, dell’Università e della Ricerca.
Abstract (Originalsprache)
Primary myelofibrosis (PMF) is hallmarked by stromal bone marrow changes, whose accurate evaluation holds diagnostic and prognostic implications. The reticulin fibrosis (MF), collagen (Co), osteosclerosis (Ost) score (RCO-S) was developed in 2017 and proved to be accurate and prognostically informative. In this retrospective, single-center study, we validated the RCO-S and explored its clinical, genetic, and prognostic correlates in a large cohort of patients with PMF, including 121 prefibrotic (pre-PMF) and 101 overt PMF (oPMF). Overall, stromal changes evolved harmonically in the 2 PMF subtypes, with pre-PMF showing milder alterations. A higher RCO-S was associated with distinct high-risk clinical and molecular features and shortened overall survival, particularly in oPMF. Receiver operator characteristic analysis confirmed 5 as the most accurate RCO-S cutoff value (RCO-S5) to differentiate low-grade (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hematopathology Unit, Department of Diagnostic Services, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy; Department of Health Sciences, University of Florence, Florence, Italy.
- Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy; Oncology Department, CRIMM, Center for Research and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliero-Universitari…
- Oncology Department, CRIMM, Center for Research and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy; Oncology Department, CRIMM, Center for Research and Innovation…
- Pathology Unit, Department of Health Sciences, University of Milan and Azienda Socio Sanitaria Territoriale Santi Paolo e Carlo, Milan, Italy; Department of Health Sciences, University of Milan, Milan, Italy.
Förderung
- Italian Association for Cancer Research
- Ministero dell’Istruzione, dell’Università e della Ricerca
Zitieren
APA
Santi, R., Coltro, G., Di Stefano, G., Atanasio, A., Cicogna, P., Loscocco, G. G., Capecchi, G., Boldrini, V., Pescia, C., Guglielmelli, P., Vannucchi, A. M., & Gianelli, U. (2025). Clinical and Prognostic Correlates of the Reticulin-Collagen-Osteosclerosis Score in Primary Myelofibrosis. Modern Pathology. https://doi.org/10.1016/j.modpat.2025.100854
Vancouver
Santi R, Coltro G, Di Stefano G, Atanasio A, Cicogna P, Loscocco GG, et al. Clinical and Prognostic Correlates of the Reticulin-Collagen-Osteosclerosis Score in Primary Myelofibrosis. Modern Pathology. 2025. doi:10.1016/j.modpat.2025.100854
BibTeX
@article{Santi2025,
author = {Santi, Raffaella and Coltro, Giacomo and Di Stefano, Gioia and Atanasio, Alessandro and Cicogna, Paolo and Loscocco, Giuseppe G and Capecchi, Giulio and Boldrini, Valentina and Pescia, Carlo and Guglielmelli, Paola and Vannucchi, Alessandro M and Gianelli, Umberto},
title = {Clinical and Prognostic Correlates of the Reticulin-Collagen-Osteosclerosis Score in Primary Myelofibrosis},
journal = {Modern Pathology},
year = {2025},
doi = {10.1016/j.modpat.2025.100854}
}
EUVIMED